高通:再為蘋果iPhone 5G供應晶片至2026年 盤前升逾5%
高通(QCOM.US)周一(11日)表示,將為蘋果(AAPL.US)智能手機供應5G晶片至2026年,打破分析師和高通高層早前預期,蘋果將從2024年開始使用內部開發的5G晶片。
高通繼續成為的蘋果供應商,減輕可能失去關鍵客戶的打擊。據瑞銀估計,高通2022財年收入442億美元,當中約有21%來自蘋果。
高通表示,預計僅供應蘋果2026年推出智能手機所需的20%晶片,表明高通仍預計向蘋果的供應最終下滑。
高通盤前升逾5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.